Incyte (INCY) Pension (2016 - 2020)

Incyte's (INCY) quarterly Pension came in at $26.2 million in Q3 2020, up 3.97% on a QoQ basis from $25.2 million in Q2 2020.

Incyte (INCY) Pension (2016 - 2020) Analysis & Trends

Incyte (INCY) has 5 years of Pension data on file, last reported at $26.2 million in Q3 2020.

Quarterly Pension changed N/A year-over-year to $26.2 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $26.2 million (changed N/A YoY) and the FY2019 annual result came in at $24.1 million, up 53.5% from the prior year.
Pension improved to $26.2 million in Q3 2020, from $25.2 million in the prior quarter.
In the past five years, Pension ranged from a high of $26.2 million in Q3 2020 to a low of $4.5 million in Q2 2016.
A 5-year average of $14.2 million and a median of $14.0 million in 2018 frame the typical range for Pension.
Annual changes were most pronounced in 2018 — Pension soared 94.44% — and 2019, when it advanced 12.86%.
Tracing INCY's Pension over 5 years: stood at $7.1 million in 2016, then soared by 88.73% to $13.4 million in 2017, then rose by 17.16% to $15.7 million in 2018, then soared by 53.5% to $24.1 million in 2019, then increased by 8.71% to $26.2 million in 2020.
The last three Pension figures came in at $26.2 million (Q3 2020), $25.2 million (Q2 2020), and $24.6 million (Q1 2020), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Incyte	24.15 Bn	19.61 Bn	1.57 Bn

Download Data